Estimating required information size by quantifying diversity in random-effects model meta-analyses.
about
Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysisHydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysisThrombolysis for acute upper extremity deep vein thrombosisContinued lamivudine for adults with lamivudine-resistant chronic hepatitis B virus infectionInterferon for people with lamivudine-resistant chronic hepatitis B virus infectionDirect-acting antivirals for chronic hepatitis CViewpoint: taking into account risks of random errors when analysing multiple outcomes in systematic reviewsN-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failureYttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinomaAntithrombin III for critically ill patientsDeliberate hypotension for orthopaedic surgerySelenium supplementation for critically ill adultsPercutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinomaProlonged storage of packed red blood cells for blood transfusionProthrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patientsHomocysteine-lowering interventions for preventing cardiovascular eventsNon-invasive positive pressure ventilation for acute asthma in childrenTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusNon-acute percutaneous coronary intervention versus medical therapy in patients with ischaemic heart diseaseBanding ligation versus sclerotherapy for primary prophylaxis of oesophageal varices in childrenPharmacotherapy for hypertension-induced left ventricular hypertrophySclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in childrenPharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine usersGlucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patientsBranched-chain amino acids for people with hepatic encephalopathyAntibiotic prophylaxis for surgical site infection in people undergoing liver transplantationStatins for primary prevention of venous thromboembolismVitamin K for upper gastrointestinal bleeding in people with acute or chronic liver diseasesAntifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liver diseaseInterventions for treating intrahepatic cholestasis in people with sickle cell diseaseSurgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhageAdefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infectionAcetyl-L-carnitine for patients with hepatic encephalopathyGemcitabine-based chemotherapy for advanced biliary tract carcinomasNutrition support in hospitalised adults at nutritional riskRifaximin for people with hepatic encephalopathyInterferon alpha versus any other drug for chronic hepatitis DDrug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinoma
P2860
Q21090716-23F8B531-3679-4872-85A3-937921CE6DE9Q22061981-D5F3D3CB-7D83-44BF-8185-D0F5ACCC4255Q22241119-43349A2D-9790-404E-AB82-22772A71DB47Q22306541-2EEC69F7-A173-45A7-B819-9428B3B177C0Q24185948-DAA21F08-0667-46FD-8C07-821530A85E0AQ24185958-5A0A29A0-F82A-4638-8EA6-6B29DE20F5B9Q24185973-17279ED7-065C-46F1-94F5-5EF2539E32EEQ24185977-60736A7F-4289-47EB-B5F1-4DA0358F3250Q24185986-EFCFFEE3-486E-4BB5-96DA-9DC48B834BEAQ24186061-C90934C1-94A9-48A8-B2A0-8325E61FF845Q24186130-F80A8072-5EA4-46B3-AE53-D4342F2D0A7EQ24186159-E5DE586B-C3E4-4D00-BD24-4C1550F38C62Q24186196-17DCBFBC-2B85-47E2-94DC-7453A2787B8CQ24186311-5B826EFC-F1B4-451B-9F30-BCAA1DE23A90Q24186496-2A309647-43CD-43E4-B2F8-61E04FD6F935Q24186513-FEF4E4C0-E7C5-4E5E-9921-D0F008A113A0Q24186523-C8B2493E-DC4E-4B24-8807-D0357F73AB4EQ24186605-D226FD75-51E0-4A96-A2BA-3575A4C7143CQ24186648-1E328442-5A42-40EF-9192-30695E2255CDQ24186667-E9B7B698-8772-4FF0-9E3F-730CD9FF413CQ24186673-E1872557-6DF8-45F0-BAE4-E8FD454AD2FEQ24186737-7727CB8C-491A-47C9-93DD-6B8998A114B2Q24186750-4273C2C2-66AA-486C-8E84-D13748C24102Q24186766-1210EE7A-0283-444C-8489-E07EC9CBFF74Q24186909-06AC093B-2B1F-40A6-8945-9E10C33E753BQ24187112-B155D4B4-2C39-47CB-96E2-9A2BCAD3D9CBQ24187134-73B7AA39-A36E-457F-8F70-852CFE51DC27Q24187200-5A157650-AD0F-4CC3-9203-05D17D29EF71Q24187238-6BA8C230-33D0-4822-BDE0-C3B4308B7D52Q24187239-DA2642A7-1633-4CAF-BF8A-F4D823E82BC8Q24187246-9A5086EB-6078-444C-B3D2-EDA456D883CDQ24187279-975EF333-8688-4983-949E-6325DC900A6DQ24187528-467E1783-9254-4AD7-B7BC-95DE14E8ABBEQ24187530-2F878ADD-33E2-46C5-9B00-A6F4E0653573Q24187553-FAC5DDA5-C24A-4E7A-8A8C-4F8E63F9EFD1Q24187573-473D22C1-8C85-44AD-A8E8-A095FDEFEE76Q24187602-E4946759-B5CF-4A1F-B045-8BE3A2A984E9Q24187627-A6ABC09B-6456-4BC2-A2C6-5D13C3FF481EQ24187640-B786FC73-7644-44DB-B7B7-00BF2829F113Q24187663-B3346088-9B9F-4EAB-808E-58CDF2126C16
P2860
Estimating required information size by quantifying diversity in random-effects model meta-analyses.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Estimating required informatio ...... m-effects model meta-analyses.
@ast
Estimating required informatio ...... m-effects model meta-analyses.
@en
Estimating required informatio ...... m-effects model meta-analyses.
@nl
type
label
Estimating required informatio ...... m-effects model meta-analyses.
@ast
Estimating required informatio ...... m-effects model meta-analyses.
@en
Estimating required informatio ...... m-effects model meta-analyses.
@nl
prefLabel
Estimating required informatio ...... m-effects model meta-analyses.
@ast
Estimating required informatio ...... m-effects model meta-analyses.
@en
Estimating required informatio ...... m-effects model meta-analyses.
@nl
P2860
P356
P1476
Estimating required informatio ...... m-effects model meta-analyses.
@en
P2093
Jesper Brok
Kristian Thorlund
P2860
P2888
P356
10.1186/1471-2288-9-86
P577
2009-12-30T00:00:00Z
P5875
P6179
1023518088